Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.

Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.
复制标题

DOI:
10.1002/eji.201344023
复制
发表时间:
2014-04
影响因子:
5.4
通讯作者:
Barnum, Scott R.
Barnum, Scott R.
中科院分区:
医学3区
文献类型:
--
作者:
Bullard, Daniel C.;Hu, Xianzhen;Crawford, David;McDonald, Kristin;Ramos, Theresa N.;Barnum, Scott R.

文献摘要

参考文献

被引文献

相似文献

细胞间粘附分子-1(ICAM-1)在白细胞运输、诱导细胞免疫应答和免疫突触形成中起重要作用。作为粘附蛋白免疫球蛋白超家族的成员,ICAM-1由重复的Ig样结构域、跨膜结构域和参与细胞内信号传导事件的短胞质尾区组成。选择性剪接产生至少7种ICAM-1蛋白亚型,但对其免疫生物学知之甚少。我们先前已经使用不同系的ICAM-1突变小鼠(Icam 1 tm 1 Jcgr和Icam 1 tm 1Bay)表明,选择性剪接的ICAM-1亚型的表达可以显着影响EAE发展过程中的疾病过程。在这项研究中,我们使用一个新开发的转基因小鼠(CD 2-Icam 1 D4 del/Icam 1 null),T细胞特异性表达的一个单一的ICAM-1亚型组成的IG域1,2,3和5,可以介导的EAE的开始和进展。我们的研究结果表明,ICAM-1亚型缺乏IG域4可以驱动脱髓鞘疾病的发病机制,并可能成为治疗多发性硬化症的一个新的治疗靶点。
Intercellular adhesion molecule-1 (ICAM-1) plays an important role in leukocyte trafficking, induction of cellular immune responses, and immunological synapse formation. As a member of the immunoglobulin superfamily of adhesion proteins, ICAM-1 is composed of repeating Ig-like domains, a transmembrane domain, and short cytoplasmic tail that participates in intracellular signaling events. At least seven ICAM-1 protein isoforms are generated by alternative splicing, however little is known regarding their immunobiology. We have previously shown using different lines of ICAM-1 mutant mice (Icam1tm1Jcgr and Icam1tm1Bay) that expression of alternatively spliced ICAM-1 isoforms can significantly influence the disease course during the development of EAE. In this study, we show using a newly developed transgenic mouse (CD2-Icam1D4del/Icam1null) that T cell-specific expression of a single ICAM-1 isoform composed of Ig domains 1, 2, 3 and 5, can mediate the initiation and progression of EAE. Our results indicate that the ICAM-1 isoform lacking Ig domain 4 can drive pathogenesis in demyelinating disease and may be a novel therapeutic target for treating multiple sclerosis.
DOI: 10.1002/eji.200839176
发表时间: 2009-06
影响因子: 5.4
作者:
Wohler, Jillian E.;Smith, Sherry S.;Zinn, Kurt R.;Bullard, Dan C.;Barnum, Scott R.
通讯作者: Barnum, Scott R.
DOI: 10.1016/j.molimm.2010.03.005
发表时间: 2010-05
影响因子: 3.6
作者:
Hu X;Barnum SR;Wohler JE;Schoeb TR;Bullard DC
通讯作者: Bullard DC
DOI: 10.1080/15419060216305
发表时间: 2002-09-01
影响因子: --
作者:
Giorelli, M;De Blasi, A;Trojano, M
通讯作者: Trojano, M
DOI: 10.1038/sj.gt.3301716
发表时间: 2002-07-01
期刊: GENE THERAPY
影响因子: 5.1
作者:
Ochietti, B;Lemieux, P;Alakhov, V
通讯作者: Alakhov, V
DOI: 10.4049/jimmunol.168.11.5792
发表时间: 2002-06-01
影响因子: 4.4
作者:
Szalai, AJ;Nataf, S;Barnum, SR
通讯作者: Barnum, SR